David Raben

Dr. Raben is nationally recognized for his work in targeted therapies and radiation, primarily in GI, head and neck cancer and lung cancer. He served on the head and neck cancer steering committee of the National Cancer Institute (NCI) sponsored radiation cooperative group (RTOG). In addition, he was a member of the genitourinary section of the Southwest Oncology Group (SWOG). Dr. Raben was the first radiation oncologist in the Rocky Mountain region to implement accelerated intensity modulated radiation to the prostate and pelvis. Dr. Raben received his medical degree from Wake Forest University, North Carolina. Dr. Raben completed his internship at the University of Hawaii Medical School, Honolulu, and his residency in radiation oncology at the Johns Hopkins Hospital. Dr. Raben currently leads the Lung, Agnostic, Skin, Head and Neck and rare Cancers (LASR) franchise in late stage development at Genentech.